Showing results (131-140 of 305) with videos related to
Sort By:
Pageof 31
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2019
Brief Report: Cocaine Use and Pre-exposure Prophylaxis: Adherence, Care Engagement, and Kidney FunctionJose Carlo Hojilla, Derek D Satre, David V Glidden, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 23, 2017
Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure ProphylaxisDavid V Glidden, Kathleen Mulligan, Vanessa McMahan, et al.AIDS (London, England)|December 11, 2020
Viral suppression during COVID-19 among people with HIV experiencing homelessness in a low-barrier clinic-based programMatthew D Hickey, Elizabeth Imbert, David V Glidden, et al.Pharmacoeconomics|March 12, 2016
Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT TrialLars Oddershede, Simon Walker, Wolfgang Stöhr, et al.AIDS (London, England)|September 11, 2015
A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UKRaphaël Mourad, François Chevennet, David T Dunn, et al.The Journal of Infectious Diseases|September 17, 2011
Transmission network parameters estimated from HIV sequences for a nationwide epidemicAndrew J Leigh Brown, Samantha J Lycett, Lucy Weinert, et al.American Journal of Epidemiology|February 7, 2012
A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in AfricaElvin H Geng, David V Glidden, David R Bangsberg, et al.Frontiers in Reproductive Health|June 11, 2024
Establishing adherence-concentration-efficacy thresholds of TDF-FTC pre-exposure prophylaxis for HIV prevention in African women: a protocol for the Women TDF-FTC Benchmark StudyLinxuan Wu, Matilda Saina, Clare Brown, et al.Health Technology Assessment (Winchester, England)|March 18, 2016
The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infectionNicholas I Paton, Wolfgang Stöhr, Lars Oddershede, et al.Critical Care Medicine|December 13, 2007
Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injuryKathleen D Liu, David V Glidden, Mark D Eisner, et al.Pageof 31